Prediction of pediatric bipolar disorder using neuroanatomical signatures of the amygdala

Benson Mwangi1, Danielle Spiker, Giovana B Zunta-Soares

  • 1Department of Psychiatry and Behavioral Sciences, University of Texas Center of Excellence on Mood Disorders, UT Houston Medical School, Houston, TX, USA.

Bipolar Disorders
|June 12, 2014
PubMed

Insights

Researchers identified structural brain differences in the amygdala to help diagnose pediatric bipolar disorder (PBD). This neuroimaging approach achieved 78% accuracy in distinguishing PBD patients from healthy youth.

Area of Science:

  • Neuroimaging
  • Child and Adolescent Psychiatry
  • Biomarker Discovery

Background:

  • Pediatric bipolar disorder (PBD) diagnosis relies on clinical symptoms, lacking objective biomarkers.
  • Existing research suggests neuroanatomical differences in PBD, particularly in the amygdala.

Purpose of the Study:

  • To investigate the utility of amygdala structural neuroanatomical signatures for objective differentiation of pediatric bipolar disorder.
  • To develop and validate a predictive model for diagnosing PBD using neuroimaging data.

Main Methods:

  • Acquired structural T1-weighted neuroimaging scans from 16 unmedicated children and adolescents with PBD and 16 matched healthy controls.
  • Utilized voxel-based gray matter morphometric features from the amygdala.
  • Developed a multivariate pattern analysis model for subject classification.

Main Results:

  • The model achieved 78.12% diagnostic accuracy in classifying subjects.
  • Sensitivity was 81.25%, specificity was 75.00%, with an AUC of 0.81.
  • The classification accuracy was statistically significant (p = 0.0014).

Conclusions:

  • Structural amygdala abnormalities are present in pediatric bipolar disorder.
  • Amygdala neuroanatomical signatures can predict individual PBD status with high accuracy.
  • This study presents a proof-of-concept for a neuroimaging-based diagnostic marker in medication-naïve pediatric patients.
Abstract